Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP034: Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn's disease patients treated with adalimumab for prevention of postoperative recurrenceECCO '17 Barcelona
Year: 2017
Authors:

Boivineau L.*1, Bourgaux J.F.2, Pineton de Chambrun G.1, Caillo L.2, Danan G.1, Boitard J.1, Liautard J.1, Guillon F.1, Altwegg R.1

1CHU St Eloi, Hepato-gastro-enterology, Montpellier, France 2CHU Nimes, Hepato-Gastro-Enterology, Nimes, France

DOP035: High gammaglobulin and low albumin serum levels independently predict secondary loss of response to anti-TNFα therapy in IBDECCO '17 Barcelona
Year: 2017
Authors:

Schoenefuss F., Hoffmann P.

Kliniken Essen Mitte, Gastroenterology, Essen, Germany

DOP036: The therapeutic efficacy of anti-TNF requires Fc-gamma receptors and can be improved by antibody hypo-fucosylationECCO '17 Barcelona
Year: 2017
Authors:

Bloemendaal F.*1, Levin A.2, Wildenberg M.2, Koelink P.2, Visser R.3, Claassens J.4, Bradford M.5, D'Haens G.2, Verbeek S.4, Vidarsson G.3, van den Brink G.2

1University of Amsterdam, Gastroenterology, Amsterdam, Netherlands 2Academic Medical Center, Gastroenterology, Amsterdam, Netherlands 3Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands 4Leiden University Medical Center, Department of Human Genetics, Leiden, Netherlands 5Abbvie Bioresearch Center, Worcester, United States

DOP037: A model for prediction of early surgery and complications in paediatric Crohn's disease: results of the prospective GROWTH CD studyECCO '17 Barcelona
Year: 2017
Authors:

Levine A.*1,2, Hussey S.3, Kolho K.L.4, Sladek M.5, de Carpi J.M.6, Turner D.7, Russell R.K.8, Cohen-Dolev N.9, Escher J.10 Porto-ECCO GROWTH CD Study Group

1Edith Wolfson Medical Center, Department of Paediatric Gastroenterology and Nutrition Unit, Holon, Israel 2Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel 3National Children's Research Centre, UCD and RCSI, Dublin, Ireland 4Children's Hospital, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland 5Jagiellonian University Medical College, Krakow, Poland 6Hospital Sant Joan de Deu, Department of Paediatric Gastroenterology, Barcelona, Spain 7Shaare Zedek Medical Center, Department of Paediatric Gastroenterology, Jerusalem, Israel 8The Royal Hospital for Children, Department of Paediatric Gastroenterology, Glasgow, United Kingdom 9Edith Wolfson Medical Center, PIBD Research Center, Department of Paediatric Gastroenterology and Nutrition Unit, Holon, Israel 10Children's Hospital Erasmus MC Sophia, Department of Paediatric Gastroenterology, Rotterdam, Netherlands

DOP038: Increased number of enteric glial cells in proximal margin of resection is associated with postoperative recurrence of Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Li Y., Zhu W., Gong J., Guo Z.

Jinling Hospital, Medical School of Nanjing University, Department of General Surgery, Nanjing, China

DOP039: Postoperative infectious complications in Crohn's disease: results from PRACTICROHN studyECCO '17 Barcelona
Year: 2017
Authors:

Gutiérrez A.*1, Taxonera C.2, García V.3, Minguez M.4, Martín Arranz M.D.5, Castro M.6, Barreiro-de Acosta M.7, Juliá B.8, Cea-Calvo L.8, Romero C.8, Domènech E.9

1Hospital General Universitario Alicante, Gastroenterology unit, Alicante, Spain 2Hospital Clinico San Carlos, Gastroenterology Unit, Madrid, Spain 3Hospital Universitario Reina Sofia, Unidad Clinica de Aparato Digestivo, Cordoba, Spain 4Unidad de Gastroenterología, Hospital General de Valencia, Valencia, Spain 5Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain 6Unidad de Gastroenterología, Hospital de Valme, Sevilla, Spain 7Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain 8MSD Spain, Medical Department, Madrid, Spain 9Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain

DOP040: Postoperative surgical recurrence in Crohn's disease decreases significantly in the biologic eraECCO '17 Barcelona
Year: 2017
Authors:

Beelen E.M.J.*1, Schouten W.R.2, Oldenburg B.3, van der Meulen-de Jong A.E.4, Ponsioen C.I.J.5, Dijkstra G.6, Pierik M.J.7, de Jong D.J.8, de Boer N.K.H.9, van der Woude C.J.1, De Vries A.C.1

1Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands 2Erasmus MC, Department of General Surgery, Rotterdam, Netherlands 3University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands 4Leiden University Medical Center, Department of Gastroenteorlogy and Hepatology, Leiden, Netherlands 5Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, Netherlands 6University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, Netherlands 7Maastricht University Medical Center (MUMC), Department of Gastroenterology and Hepatology, Maastricht, Netherlands 8Radboud University Medical Centre, Department of Gastroenterology and Hepatology, Nijmegen, Netherlands 9VU University Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands

DOP041: Prepouch ileitis after ileal pouch anal anastomosis for ulcerative colitis: patterns of presentation and risk factors for failure of treatmentECCO '17 Barcelona
Year: 2017
Authors:

Rottoli M., Vallicelli C., Bigonzi E., Di Simone M., Gionchetti P., Boschi L., Poggioli G.

Alma Mater Studiorum University of Bologna, Sant'Orsola - Malpighi Hospital, Digestive Disease, Bologna, Italy

DOP042: Omentectomy is not necessary during laparoscopic total coloproctectomy and ileal pouch-anal anastomosis for inflammatory bowel disease. A comparative study in 247 consecutive patients from 4 expert centresECCO '17 Barcelona
Year: 2017
Authors:

Mege D.*1, Germain A.2, Stellingwerf M.3, Colombo F.4, Maggiori L.1, De Buck van Overstraeten A.2, Buskens C.3, Foschi D.4, Sampietro G.4, Bemelman W.3, D'Hoore A.2, Panis Y.1

1Beaujon Hospital, Colorectal Surgery, Clichy, France 2Leuven, Digestive Surgery, leuven, Belgium 3AMC, Digestive Surgery, Amsterdam, Netherlands 4ASST, Digestive Surgery, Milan, Italy

DOP043: High risk of pouch dysplasia in IBD-PSC patients following total proctocolectomyECCO '17 Barcelona
Year: 2017
Authors:

Palmela C.*1,2, Castaneda D.3, Shah S.1, ten Hove J.4, Ullman T.1, Itzkowitz S.H.1, Torres J.1,2

1Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, United States 2Hospital Beatriz Ângelo, Department of Gastroenterology, Loures, Portugal 3Mount Sinai St. Luke's and Mount Sinai West Hospitals, Division of Internal Medicine, New York, United States 4University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands

DOP044: Relationship between microbiota and development of early postoperative Crohn's disease recurrenceECCO '17 Barcelona
Year: 2017
Authors:

Machiels K.*1, Pascal V.2, Sabino J.1, Santiago A.2, Campos D.2, Wolthuis A.3, De Buck van Overstraeten A.3, D'Hoore A.3, Van Assche G.1, Ferrante M.1, Rutgeerts P.1, Manichanh C.2, Vermeire S.1

1University Hospitals Leuven, KU Leuven, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium 2Vall d'Hebron Research Institute, Barcelona, Spain 3University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium

DOP045: Post-operative complications in elderly-onset inflammatory bowel disease: a population-based studyECCO '17 Barcelona
Year: 2017
Authors:

Sacleux S.-c.*1, Charpentier C.1, Sarter H.2, Fumery M.3, Guillon-Dellac N.4, Laberenne E.5, Pariente B.6, Peyrin-biroulet L.7, Gower-Rousseau C.8, Savoye G.1

1CHU Rouen, Department of Gastroenterology and Hepatology, Rouen, France 2CHRU Lille, Department of Biostatistics EA 2694, Lille, France 3Amiens University Hospital, Department of Gastroenterology and Hepatology, Amiens, France 4CHRU Lille, Department of Epidemiology, Lille, France 5CH Seclin, Department of Gastroenterology, Seclin, France 6CHRU Lille, Department of Gastroenterology, Lille, France 7CHU Nancy, Department of Gastroenterology and Hepatology, Vandoeuvre-Lès-Nancy, France 8CHRU Lille, Department of Epidemiology, EPIMAD Registry, Lille, France

DOP046: Genome-wide association study of baseline disease characteristics and response to Ustekinumab in moderate to severe Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Hart A., Li K., Gasink C., Jacobstein D., Brodmerkel C.

Janssen Research & Development, LLC, Spring House, United States

DOP047: Early fibrostenosis in Crohn's disease is associated with multiple susceptibility loci on Immunochip analysisECCO '17 Barcelona
Year: 2017
Authors:

Holvoet T.*1, Bossuyt P.2,3, Cleynen I.3, De Kock I.4, Hindryckx P.1, Vermeire S.3,5, Laukens D.1, De Vos M.1

1Ghent University Hospital, Dept. of Gastroenterology, Ghent, Belgium 2Imelda GI Clinical Research Center, Dept. of Gastroenterology, Bonheiden, Belgium 3University Hospitals Leuven, Dept. of Gastroenterology, Leuven, Belgium 4Ghent University Hospital, Radiology, Ghent, Belgium 5Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Dept. of Clinical and Experimental Medicine, Leuven, Belgium

DOP048: PROFILE trial: predicting outcomes for Crohn's disease using a molecular biomarkerECCO '17 Barcelona
Year: 2017
Authors:

Lee J.1,2, Biasci D.1, Noor N.*1,2, McKinney E.1, Ahmad T.3,4, Lewis N.5, Hart A.6,7, Lyons P.1, Parkes M.1,2, Smith K.1

1University of Cambridge, School of Clinical Medicine, Cambridge, United Kingdom 2Addenbrooke's Hospital NHS Trust, Department of Gastroenterology, Cambridge, United Kingdom 3University of Exeter, Exeter IBD and Pharmacogenetics Research Group, Exeter, United Kingdom 4Royal Devon and Exeter NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom 5Nottingham University Hospitals NHS Trust, Department of Gastroenterology, Nottingham, United Kingdom 6St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom 7Imperial College, Faculty of Medicine, Department of Surgery & Cancer, London, United Kingdom

DOP049: Inflammatory dyskinesis: defects of NF-κB dynamic behaviour as a new potential biomarker for personalized medicine in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Sellge G.*1, Papoutsopoulou S.2, Verdier J.1, Trautwein C.1, Bergey F.3, Burkitt M.4, Burkitt M.4, Sheibani R.5, Pierik M.6, Jonkers D.6, White M.2, Paszek P.2, Martins dos Santos V.3, Rosenstiel P.5, Müller W.2, Probert C.4 SysmedIBD Consortium2

1University Hospital RWTH Aachen, Department of Internal Medicine III, Aachen, Germany 2University of Manchester, Faculty of Life Sciences, Manchester, United Kingdom 3LifeGlimmer GmbH, Berlin, Germany 4University of Liverpool, Cellular and Molecular Physiology, Liverpool, United Kingdom 5Kiel University, Institute of Clinical Molecular Biology, Kiel, Germany 6Maastricht University Medical Centre, Division Gastroenterology-Hepatology, Maastricht, Netherlands

DOP050: Serum proteomic analysis defines novel circulating inflammatory markers for Crohn's disease and response to anti-TNF therapyECCO '17 Barcelona
Year: 2017
Authors:

Korf H.*1,2, Sabino J.1, Ballet V.3, de Bruyn M.1,4, Van Assche G.3, Ferrante M.3, Vermeire S.3

1KULeuven, Translational Research in Gastrointestinal Disorders (TARGID), Clinical and Experimental Medicine, Leuven, Belgium 2KULeuven, Laboratory of Hepatology, Clinical and Experimental Medicine, Leuven, Belgium 3UZLeuven, Department of Gastroenterology and Hepatology, Leuven, Belgium 4KULeuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Leuven, Belgium

DOP051: Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

van Haaften W.T.*1,2, Mortensen J.H.3, Olesen M.L.3,4, Karsdal M.A.3, Olinga P.2, Bay-Jensen A.-C.3, Dijkstra G.1

1University Medical Center Groningen, University of Groningen, Department of Gastro-enterology and Hepatology, Groningen, Netherlands 2University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, Netherlands 3Nordic Bioscience, Biomarkers and Research, Herlev, Denmark 4Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark

DOP052: Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein and biopsy gene expression analysis: results from Ustekinumab phase 3 studiesECCO '17 Barcelona
Year: 2017
Authors:

Li K., Hayden K., Wadman E., Bhagat S., Emrich S., Jacobstein D., Gasink C., Brodmerkel C.

Janssen Research & Development, LLC, Spring House, Pennsylvania, United States

DOP053: The fecal microbiome as a tool for monitoring and predicting response outcomes in ustekinumab-treated, anti-TNFα refractory Crohn's disease patients: results from the CERTIFI studyECCO '17 Barcelona
Year: 2017
Authors:

Doherty M.K.*1, Koumpouras C.1, Telesco S.E.2, Monast C.2, Brodmerkel C.2, Schloss P.D.1

1University of Michigan Medical School, Department of Microbiology and Immunology, Ann Arbor, United States 2Janssen Research & Development, LLC, Spring House, United States